Literature DB >> 6956869

Serological analysis of cell surface antigens of null cell acute lymphocytic leukemia by mouse monoclonal antibodies.

R Ueda, M Tanimoto, T Takahashi, S Ogata, K Nishida, R Namikawa, Y Nishizuka, K Ota.   

Abstract

Nine antigens systems were defined. Two were related to HLA-A,B,C and to Ia-like antigens; the others could be grouped into three categories. (i) NL-22, NL-1: NL-22 antibody reacted with leukemia cells from 12 to 16 cases of null cell acute lymphocytic leukemia (null-ALL) but not with any other type of leukemia tested or with lymphoid cells of various origins. Among cultured cell lines tested, one (NALM-6) of three null-ALL cell lines was positive, the others were negative. Absorption analysis confirmed the restriction of NL-22 antigen to null-ALL. NL-1 antibody was reactive with leukemia cells from 10 to 16 cases of null-ALL and 3 of 6 cases of chronic myelocytic leukemia in blastic crisis (CML-BC). The antigen was present also on a minor population of normal lymphoid cells. The distribution and molecular weight (100,000; glycoprotein) of the NL-1 antigen resembled that of the previously described common ALL antigen (cALL). (ii) NL-30, NL-4: Both antibodies exhibited almost identical patterns of reactivities against cultured cell lines tested. They reacted with leukemia cells from some cases of null-ALL, adult T-cell leukemia, and CML-BC, although they showed discordance in their reactivities against a panel of leukemia cells, (iii) NL-9, NL-8, NL-25: These three antibodies detect serologically distinguishable determinants on a broad range of leukemias and normal lymphoid and hematopoietic cell types. The antibodies analyzed in this study provide evidence for the heterogeneity of null-ALL by demonstrating a variety of antigen phenotypes on leukemia cells. One of the antigens (NL-22) appears to be restricted to null-ALL.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6956869      PMCID: PMC346676          DOI: 10.1073/pnas.79.14.4386

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  26 in total

1.  Antisera to acute lymphoblastic leukemia cells.

Authors:  M F Greaves; G Brown; N T Rapson; T A Lister
Journal:  Clin Immunol Immunopathol       Date:  1975-05

2.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

3.  A new micro-method for quantitation of human T- and B-lymphocytes.

Authors:  T Tachibana; M Ishikawa
Journal:  Jpn J Exp Med       Date:  1973-06

4.  Isolation of mononuclear cells and granulocytes from human blood. Isolation of monuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g.

Authors:  A Böyum
Journal:  Scand J Clin Lab Invest Suppl       Date:  1968

5.  Acute lymphoblastic leukemia (ALL) antigens detected with antisera to E rosette-froming and non-E rosette-forming ALL blasts.

Authors:  L Borella; L Sen; J T Casper
Journal:  J Immunol       Date:  1977-01       Impact factor: 5.422

6.  Expression of common acute lymphoblastic leukemia antigen (CALLA) by lymphomas of B-cell and T-cell lineage.

Authors:  J Ritz; L M Nadler; A K Bhan; J Notis-McConarty; J M Pesando; S F Schlossman
Journal:  Blood       Date:  1981-09       Impact factor: 22.113

7.  Cell surface antigens of human renal cancer defined by mouse monoclonal antibodies: identification of tissue-specific kidney glycoproteins.

Authors:  R Ueda; S Ogata; D M Morrissey; C L Finstad; J Szkudlarek; W F Whitmore; H F Oettgen; K O Lloyd; L J Old
Journal:  Proc Natl Acad Sci U S A       Date:  1981-08       Impact factor: 11.205

8.  P-24: a human leukemia-associated and lymphohemopoietic progenitor cell surface structure identified with monoclonal antibody.

Authors:  J H Kersey; T W LeBien; C S Abramson; R Newman; R Sutherland; M Greaves
Journal:  J Exp Med       Date:  1981-03-01       Impact factor: 14.307

9.  Cell surface antigens of human malignant melanoma. II. Serological typing with immune adherence assays and definition of two new surface antigens.

Authors:  H Shiku; T Takahashi; H F Oettgen
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307

10.  Distribution of common acute lymphoblastic leukemia antigen in nonhematopoietic tissues.

Authors:  R S Metzgar; M J Borowitz; N H Jones; B L Dowell
Journal:  J Exp Med       Date:  1981-10-01       Impact factor: 14.307

View more
  7 in total

1.  Five antigens on human T cells detected by mouse monoclonal antibodies.

Authors:  I Tsuge; R Ueda; K Nishida; R Namikawa; M Seto; T Maruyama; S Takamoto; H Matsuoka; S Torii; K Ota
Journal:  Clin Exp Immunol       Date:  1984-11       Impact factor: 4.330

2.  Immunological studies on adult T cell leukaemia virus (ATLV) carriers.

Authors:  Y Morishima; K Ohya; T Morishima; K Nishikawa; T Fukuda
Journal:  Clin Exp Immunol       Date:  1986-06       Impact factor: 4.330

3.  Expression of CD10/neutral endopeptidase in normal and malignant tissues of the human stomach and colon.

Authors:  Y Sato; F Itoh; Y Hinoda; Y Ohe; N Nakagawa; R Ueda; A Yachi; K Imai
Journal:  J Gastroenterol       Date:  1996-02       Impact factor: 7.527

4.  Ontogenic development of T and B cells and non-lymphoid cells in the white pulp of human spleen.

Authors:  R Namikawa; T Mizuno; H Matsuoka; H Fukami; R Ueda; G Itoh; M Matsuyama; T Takahashi
Journal:  Immunology       Date:  1986-01       Impact factor: 7.397

Review 5.  Antigens of melanocytes and melanoma.

Authors:  S A Lynch; B N Bouchard; S Vijayasaradhi; H Yuasa; A N Houghton
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

6.  Phenotypic heterogeneity of melanoma. Relation to the differentiation program of melanoma cells.

Authors:  A N Houghton; F X Real; L J Davis; C Cordon-Cardo; L J Old
Journal:  J Exp Med       Date:  1987-03-01       Impact factor: 14.307

7.  Phenotypic profile of human neuroblastoma cell lines: association with morphological characteristics.

Authors:  Y Komada; E Azuma; H Kamiya; M Sakurai
Journal:  Br J Cancer       Date:  1986-10       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.